We are live on ! Find out more

3,974 hedge funds and large institutions have $280B invested in Merck in 2026 Q3 according to their latest regulatory filings, with 306 funds opening new positions, 1,589 increasing their positions, 1,599 reducing their positions, and 112 closing their positions.

New
Increased
Maintained
Reduced
Closed

173% more first-time investments, than exits

New positions opened: 306 | Existing positions closed: 112

40% more funds holding in top 10

Funds holding in top 10: 78 → 109 (+31)

12% more call options, than puts

Call options by funds: $4.49B | Put options by funds: $4.02B

2% more funds holding

Funds holding: 3,879 → 3,974 (+95)

1% less repeat investments, than reductions

Existing positions increased: 1,589 | Existing positions reduced: 1,599

2.71% less ownership

Funds ownership: 80.81% → 78.1% (-2.7%)

41% less capital inflows, than outflows

Capital inflows: $10.9B | Capital outflows: $18.6B

Holders
3,974
Holders Change
+95
Holders Change %
+2.45%
% of All Funds
48.35%
Holding in Top 10
109
Holding in Top 10 Change
+31
Holding in Top 10 Change %
+39.74%
% of All Funds
1.33%
New
306
Increased
1,589
Reduced
1,599
Closed
112
Calls
$4.49​B
Puts
$4.02​B
Net Calls
+$466​M
Net Calls Change
+$385​M

MRK Hedge Fund Activity: Q3 2026 in Review

3,974 of the 8,220 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q3 2026, worth a combined $280B — up 9.4% from $256B a quarter earlier.

Buyers outnumbered sellers: 306 funds opened new MRK positions and 112 closed out — a net gain of 194 holders — while 1,589 added to existing stakes and 1,599 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $1.12B. The largest seller was Royal Bank of Canada, cutting an estimated $2.03B.

  • 3,974 institutional investors held Merck (MRK) as of Q3 2026, up from 3,879 in Q2 2026.
  • Funds reported $280B of Merck stock for Q3 2026, up 9.4% quarter-over-quarter.
  • 306 funds opened new Merck positions in Q3 2026 and 112 closed out, a net change of +194 holders.
  • The largest Merck buyer in Q3 2026 was T. Rowe Price Associates, an estimated $1.12B added.
  • The largest Merck seller in Q3 2026 was Royal Bank of Canada, an estimated $2.03B sold.

Based on aggregated 13F filings for Q3 2026.